Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs

NCT02943733 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped closed per sponsor request, for slow enrollment

Conditions

Neuroendocrine Tumors
Neoplasms
Cancer
Tumors

Interventions

DRUG: TAS-102
DRUG: Temozolomide
DRUG: Filgrastim
DRUG: Pegfilgrastim

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]